Supplementary Table S3 from Association Between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer

Supplementary Table S3. Univariable and multivariable analysis of PFS Abbreviations: ECOG PS, Eastern Cooperative Oncology Group performance status; HR, hazard ratio; ICI, immune checkpoint inhibitor; IHC, immunohistochemistry; irAE, immune-related adverse event; PD-L1, programmed death ligand-1; PFS, progression-free survival; TPS, tumor proportion score.